Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIgamma (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIgamma markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIgamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonization resistance takes place through direct (not requiring host involvement) or indirect mechanisms (ultimately mediated by the host response, as mentioned above for the modulation of AMPs) [18, 19].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Systemic administration of TLR-5 agonist flagellin, or oral administration of TLR-4 agonist LPS, were shown to reinstate resistance to VRE or C. difficile in mice previously treated with antibiotics, through restoration of RegIII-γ production [18-20].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a defect that can be reverted by oral administration of LPS [18]”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
In the citing paper
“even short-term antibiotic treatment impairs its expression, rendering mice susceptible to vancomycin-resistant enterococcus (VRE) infection”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.966 · Cited by 751
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Cited by
Items 201–300 of 630
Probiotics as Antibiotic Alternatives for Human and Animal Applications
Rabetafika, H. N., Razafindralambo, A., Ebenso, B., & Razafindralambo, H. L. (2023) · Encyclopedia · doi:10.3390/encyclopedia3020040 · Cited by 116
“The ability of commensals to outcompete pathogens for space and nutrients, as well as enhancing the host defense of the colonic epithelium, actively protect the host against infections [37,38].”
BackgroundThe Role of the Microbiota in Shaping Infectious Immunity
Hand, T. W. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.007 · Cited by 92
“Interestingly, these innate responses do not always target the bacteria initiating the TLR response implying that the microbiota and immune response can work together via these innate mechanisms to eliminate some organisms (AMPs) while feeding others (fucosylation) [19].”
BackgroundThe impact of intestinal inflammation on the nutritional environment of the gut microbiota
Faber, F., & Bäumler, A. J. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.04.014 · Cited by 93
Menendez, A., Willing, B. P., Montero, M., Wlodarska, M., So, C. C., Bhinder, G., Vallance, B. A., & Finlay, B. B. (2013) · Journal of Innate Immunity · doi:10.1159/000341630 · Cited by 93
Tedim, A. P., Ruíz-Garbajosa, P., Corander, J., Rodríguez, C. M., Cantón, R., Willems, R. J. L., Baquero, F., & Coque, T. M. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03661-14 · Cited by 107
Genome-based insights into the evolution of enterococci
van Schaik, W., & Willems, R. J. L. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03201.x · Cited by 91
“Interestingly, a recent study directly linked the use of broad-spectrum antibiotics to colonization by vancomycin-resistant enterococci (VRE) by showing that, upon antibiotic therapy, lower levels of the C-type lectin RegIIIc are produced by the host, resulting in markedly decreased killing of VRE in the intestine of…”
BackgroundEnlisting commensal microbes to resist antibiotic-resistant pathogens
Keith, J. W., & Pamer, E. G. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180399 · Cited by 87
Self-citationRoadblocks in the gut: barriers to enteric infection
Gill, N., Wlodarska, M., & Finlay, B. B. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01578.x · Cited by 87
“In addition, RegIIIg is important for controlling the population of some Gram-positive opportunistic pathogens, as its depletion facilitates the growth of vancomycin resistant Enterococcus (Brandl et al., 2008).”
BackgroundImmune responses to gut microbiota-commensals and pathogens
Tanoue, T., Umesaki, Y., & Honda, K. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12613 · Cited by 88
“IL-22 acts on epithelial cells to produce a secreted C-type lectin, RegIIIγ, which kills Gram-positive bacteria, including vancomycin-resistant Enterococcus (VRE).(2,5,42) It is also known that MyD88-dependent TLR activation in Paneth cells by commensals plays a critical role in the production of RegIIIγ and RegIIIβ.”
BackgroundKaur, J. P., Cao, X., Abutaleb, N. S., Elkashif, A., Graboski, A. L., Krabill, A. D., AbdelKhalek, A., An, W., Bhardwaj, A., Seleem, M. N., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00734 · Cited by 90
Microbiotal influence on T cell subset development
Atarashi, K., Umesaki, Y., & Honda, K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.010 · Cited by 95
Crozat, K., Vivier, E., & Dalod, M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00736.x · Cited by 86
Rigottier‐Gois, L., Madec, C., Navickas, A., Matos, R. C., Akary, E., Mistou, M., & Serror, P. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu402 · Cited by 90
“lectin active against vancomycin-resistant enterococci [3, 6].”
Immunoregulation by the gut microbiota
Nishio, J., & Honda, K. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0993-6 · Cited by 95
Commensal gut flora and brain autoimmunity: a love or hate affair?
Berer, K., & Krishnamoorthy, G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0949-9 · Cited by 82
“For example, the elimination of commensal bacteria by antibiotic treatment markedly reduced the expression of the antibacterial lectin RegIIIc [16].”
BackgroundKeeping bugs in check: The mucus layer as a critical component in maintaining intestinal homeostasis
Faderl, M., Noti, M., Corazza, N., & Mueller, C. (2015) · IUBMB Life · doi:10.1002/iub.1374 · Cited by 81
Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
Brandl, K., & Schnabl, B. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1057122 · Cited by 82
Self-citationColonization Resistance of the Gut Microbiota against Clostridium difficile
Pérez-Cobas, A., Moya, A., Gosalbes, M., & Latorre, A. (2015) · Antibiotics · doi:10.3390/antibiotics4030337 · Cited by 83
“difficile [148].”
Effector and memory T cell responses to commensal bacteria
Belkaid, Y., Bouladoux, N., & Hand, T. W. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.003 · Cited by 81
Th17 cytokines and host-pathogen interactions at the mucosa: Dichotomies of help and harm
Liu, J. Z., Pezeshki, M., & Raffatellu, M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.07.005 · Cited by 92
“Induction of Reg3γ is also important to limit growth of vancomycin-resistant enterococci in the gut [41].”
BackgroundSadaka, A., Durand, M. L., & Gilmore, M. S. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.03.004 · Cited by 82
“Interestingly, it has been found to be downregulated in the intestines of mice after treatment with antibiotics (Brandl et al., 2008) as the result of the elimination of flagellated gram negatives, which gratuitously stimulate its production through TLR5 (Kinnebrew et al.”
Guidance on the safety assessment of Enterococcus faecium in animal nutrition
(FEEDAP), E. P. O. A. A. P. O. S. U. I. A. F. (2012) · EFSA Journal · doi:10.2903/j.efsa.2012.2682 · Cited by 79
“Additionally, when the gram-negative intestinal bacteria are suppressed by antibiotics, there is down regulation of the anti-enterococcal host-derived lectin RegIII gamma, which allows enterococci to proliferate (Brandl et al., 2008).”
Yu, H., Wang, Y., Zeng, X., Cai, S., Wang, G., Liu, L., Huang, S., Li, N., Liu, H., Ding, X., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901717r · Cited by 84
Shi, Y., Kellingray, L., Zhai, Q., Gall, G. L., Narbad, A., Zhao, J., Zhang, H., & Chen, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01948 · Cited by 86
“Microbiota-derived LPS maintains basal level expression of RegIIIγ in intestinal epithelial cells; RegIIIγ is not detected in germ-free mice and was impaired by short-term antibiotic treatments evaluated in previous studies (Cash et al., 2006; Brandl et al., 2008).”
BackgroundZeineldin, M. M., Aldridge, B. M., & Lowe, J. F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01035 · Cited by 96
“Selective pressure from antimicrobial exposure is exploited by antimicrobial-resistant microbes, providing them with an evolutionary advantage (Brandl et al., 2008).”
BackgroundChandra, H., Sharma, K. K., Tuovinen, O. H., Sun, X., & Shukla, P. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1979882 · Cited by 88
Mechanisms of antimicrobial resistance among hospital-associated pathogens
Khan, A., Miller, W. R., & Arias, C. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1456919 · Cited by 92
Expression and functional importance of innate immune receptors by intestinal epithelial cells
Marques, R., & Boneca, I. G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0829-9 · Cited by 76
“These modifications lead consequently to an impaired resistance to different bacterial infections [111, 112] if a normal gut flora is not restored.”
BackgroundGut microbiota on admission as predictive biomarker for acute necrotizing pancreatitis
Zou, M., Yang, Z., Fan, Y., Gong, L., Han, Z., Li, J., Hu, X., & Wu, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988326 · Cited by 82
“Depletion of the Gram-negative microbiota weakens the antimicrobial activity towards Gram-positive bacteria including enterococci, leading to overgrowth of enterococci (53, 54).”
BackgroundConventional CD4+ T cells regulate IL-22-producing intestinal innate lymphoid cells
Korn, L. L., Thomas, H. L., Hubbeling, H. G., Spencer, S. P., Sinha, R., Simkins, H. M., Salzman, N. H., Bushman, F. D., & Laufer, T. M. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.121 · Cited by 75
Hendrickx, A. P. A., Top, J., Bayjanov, J. R., Kemperman, H., Rogers, M. R. C., Paganelli, F. L., Bonten, M. J. M., & Willems, R. J. L. (2015) · mBio · doi:10.1128/mbio.01346-15 · Cited by 82
Ross, C. L., Spinler, J. K., & Savidge, T. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.006 · Cited by 87
Interaction of Salmonella spp. with the Intestinal Microbiota
Ahmer, B. M. M., & Gunn, J. S. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00101 · Cited by 74
“…as well as NLRP3 (NLR family pyrin domain containing; previously NALP3) and NLRC4 (NLR family CARD domain containing; previously IPAF [IL-1β-converting enzyme protease activating factor]), both of which activate caspase-1 in response to S. Typhimurium (Grassl and Finlay, 2008; Broz et al., 2010).”
Microbiota-mediated protection against antibiotic-resistant pathogens
Panwar, R., Sequeira, R. P., & Clarke, T. B. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00129-5 · Cited by 80
“Simple restoration of a pure TLR agonist was sufficient to stimulate this immune defense pathway and protect against VRE [43].”
BackgroundHost immune response to antibiotic perturbation of the microbiota
Wlodarska, M., & Finlay, B. B. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.135 · Cited by 75
Gabarre, P., Loens, C., Tamzali, Y., Barrou, B., Jaisser, F., & Tourret, J. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16836 · Cited by 85
Jang, K. K., Heaney, T., London, M., Ding, Y., Putzel, G., Yeung, F., Ercelen, D., Chen, Y.-H., Axelrad, J., Gurunathan, S., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.002 · Cited by 70
The role of bacterial translocation in sepsis: a new target for therapy
Potruch, A., Schwartz, A., & Ilan, Y. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221094214 · Cited by 75
The microbiota: a crucial mediator in gut homeostasis and colonization resistance
Chen, Y., Xiao, L., Zhou, M., & Zhang, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1417864 · Cited by 100
“…molecules such as lipopolysaccharide (LPS) or bacterial flagellin could increase the expression of RegIII γ and enhance the eradication of vancomycin-resistant enterococci (VRE) species (Brandl et al., 2008; Kinnebrew et al., 2010), showing the microbiota can strengthen the gut barrier.”
BackgroundMcKenney, P. T., Yan, J., Vaubourgeix, J., Becattini, S., Lampen, N., Motzer, A., Larson, P. J., Dannaoui, D., Fujisawa, S., Xavier, J. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2019.03.008 · Cited by 77
“During colonization of the intestine, formation of chains by VRE in response to bile acids could be advantageous for adherence to host surfaces, but may also increase the likelihood of binding by RegIIIγ and IgA and adherence of VRE to feces destined for excretion.”
BackgroundSelf-citationThe Gut Microflora and Its Variety of Roles in Health and Disease
Frick, J.-S., & Autenrieth, I. B. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_217 · Cited by 86
“This immune deficit seems to be caused by antibioticmediated disruption of the gut microbiota and helps VRE to prolong their colonization of the mouse intestine (Brandl et al. 2008).”
BackgroundLiu, T., Sun, Z., Yang, Z., & Qiao, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114586 · Cited by 73
Luchen, C. C., Chibuye, M., Spijker, R., Simuyandi, M., Chisenga, C. C., Bosomprah, S., Chilengi, R., Schultsz, C., Mende, D. R., & Harris, V. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004235 · Cited by 82
Barnett, M. P., McNabb, W. C., Cookson, A. L., Zhu, S., Davy, M., Knoch, B., Nones, K., Hodgkinson, A. J., & Roy, N. C. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-39 · Cited by 67
“In our study, the fact that expression levels of both Reg3b and Reg3g were lower in Il10-/- mice inoculated with Enterococcus strains relative those in the C and CIF groups may reflect an inability of these mice to appropriately respond to this inoculation, and a failure to effectively deal with the additional enteroc…”
BackgroundLactobacillus GG and Tributyrin Supplementation Reduce Antibiotic‐Induced Intestinal Injury
Cresci, G., Nagy, L. E., & Ganapathy, V. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113486809 · Cited by 67
“Vancomycin, neomycin, and metronidazole eliminate Gram-positive, Gram-negative, and anaerobic commensal bacteria.(29) Administration of this antibiotic combination not only depletes and alters the gut microbiota community richness and structure,(37) thus providing space and nutrients for opportunistic pathogenic bacte…”
BackgroundMethodInfluentialThe Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes
Jończyk-Matysiak, E., Łusiak-Szelachowska, M., Kłak, M., Bubak, B., Międzybrodzki, R., Weber-Dąbrowska, B., Żaczek, M., Fortuna, W., Rogóż, P., Letkiewicz, S., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/482863 · Cited by 65
Wang, E., Yuan, Z., Wang, K., Gao, D., Liu, Z., & Liles, M. R. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.11.019 · Cited by 73
Lytic Bacteriophages Facilitate Antibiotic Sensitization of Enterococcus faecium
Canfield, G. S., Chatterjee, A., Espinosa, J., Mangalea, M. R., Sheriff, E. K., Keidan, M., McBride, S. W., McCollister, B. D., Hang, H. C., & Duerkop, B. A. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00143-21 · Cited by 70
“Cephalosporin activity pressures the native intestinal microbiota altering its ecology and related 394 mucosal immunity, creating a scenario for enterococci to thrive and become dominant members of the 395 microbiota (33-36).”
BackgroundRea, M. C., Alemayehu, D., Ross, R. P., & Hill, C. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.058933-0 · Cited by 76
The Impact of Enterococcus spp. in the Immunocompromised Host: A Comprehensive Review
Sangiorgio, G., Calvo, M., Migliorisi, G., Campanile, F., & Stefani, S. (2024) · Pathogens · doi:10.3390/pathogens13050409 · Cited by 75
Ohnmacht, C., Marques, R., Presley, L., Sawa, S., Lochner, M., & Eberl, G. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01577.x · Cited by 65
“, 2007), cancer (Davis and Milner, 2009), skin and mucosal disorders and infection (Brandl et al., 2008; Lai et al., 2009), and altering behaviour (Gareau et al.”
BackgroundGut Microbiota and Host Reaction in Liver Diseases
Fukui, H. (2015) · Microorganisms · doi:10.3390/microorganisms3040759 · Cited by 65
“MyD88-dependent Reg3g shows a potent bactericidal activity in intestinal epithelial and Paneth cells [27,28].”
BackgroundImpact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients
Benus, R. F., Harmsen, H. J., Welling, G. W., Spanjersberg, R., Zijlstra, J. G., Degener, J. E., & van der Werf, T. S. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1826-4 · Cited by 63
Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children
Whittaker, E., López‐Varela, E., Broderick, C. M., & Seddon, J. A. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00233 · Cited by 77
An overview of host‐derived molecules that interact with gut microbiota
Zhang, C., Liu, H., Sun, L., Wang, Y., Chen, X., Du, J., Sjöling, Å., Yao, J., & Wu, S. (2023) · iMeta · doi:10.1002/imt2.88 · Cited by 66
“(2) Regenerating (Reg) protein family is produced by Paneth cells and can kill Listeria monocytogenes [17], Enterococcus [18], and Yersinia pseudotuberculosis [19], but prolong the infections with S. Typhimurium [20].”
BackgroundZhang, M., Shan, C., Tan, F., Limbu, S. M., Chen, L., & Du, Z. (2019) · Aquaculture · doi:10.1016/j.aquaculture.2019.734800 · Cited by 64
Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation
Ramadan, A. M., & Paczesny, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00014 · Cited by 72
“In inflammatory bowel disease (100), it has been reported that Reg3α in humans or RegIIIγ, the homologous mouse protein, has an antimicrobial function, controlling bacterial proliferation (101, 102).”
BackgroundWebb, B. J., Healy, R., Majers, J., Burr, Z., Gazdik, M. A., Lopansri, B. K., Hoda, D., Petersen, F. B., & Ford, C. D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix232 · Cited by 61
G.I. pros: Antimicrobial defense in the gastrointestinal tract
Chung, L. K., & Raffatellu, M. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.02.001 · Cited by 66
Lin, X., Yang, J., Peng, X., & Li, H. (2010) · Journal of Proteome Research · doi:10.1021/pr100740w · Cited by 60
Li, J., Hao, H., Cheng, G., Liu, C., Ahmed, S., Shabbir, M. A. B., Hussain, H. I., Dai, M., & Yuan, Z. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01711 · Cited by 66
“(2008) showed that depletion of commensal microbes in response to broad-spectrum antibiotics can provide space and nutrients for pathogenic organisms, reduce the antimicrobial molecules in the intestinal mucosa, impair the mucosal innate immune defenses and lead to the increasing susceptibility to proliferated vancomy…”
BackgroundResultInfluentialFiore, E., Tyne, D. V., & Gilmore, M. S. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch24 · Cited by 72
Bacterial extracellular vesicles at the interface of gut microbiota and immunity
Melo-Marques, I., Cardoso, S. M., & Empadinhas, N. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2396494 · Cited by 67
“162 BEVs have a dual role in colonization resistance.”
BackgroundThe dynamic influence of commensal bacteria on the immune response to pathogens
Abt, M. C., & Artis, D. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.12.002 · Cited by 75
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript vancomycin-resistent Enterococcus [30].”
Collateral Damage: Microbiota-Derived Metabolites and Immune Function in the Antibiotic Era
Lopez, C. A., Kingsbury, D. D., Velazquez, E. M., & Bäumler, A. J. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.07.009 · Cited by 59
“…of mice with a combination of metronidazole, neomycin and vancomycin lowers intestinal expression of the antimicrobial peptide RegIII-γ, suggesting that the ability of the gut-associated microbial community to fortify barrier functions can be impaired by antibiotic treatment (Brandl et al., 2008).”
BackgroundPathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness
Cho, N. A., Strayer, K., Dobson, B., & McDonald, B. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2351478 · Cited by 66
“75 However, the contribution of antimicrobial treatments toward AMR in critical illness may depend on the dose, route, and timing of broad-spectrum antibiotic use.”
BackgroundHafez, M., Hayes, K., Goldrick, M., Warhurst, G., Grencis, R., & Roberts, I. S. (2009) · Infection and Immunity · doi:10.1128/iai.00040-09 · Cited by 59
“Without these signals, susceptibility to antibiotic-resistant strains of bacteria develops (9).”
BackgroundAntibiotic Resistance and Microbiota Response
Santacroce, L., Domenico, M. D., Montagnani, M., & Jirillo, E. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221219093450 · Cited by 64
Shepherd, J., Sarker, P. K., Swindells, K., Douglas, I., MacNeil, S., Swanson, L., & Rimmer, S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja907466y · Cited by 57
Yin, J., Ren, W., Wei, B., Huang, H., Li, M., Wu, X., Wang, A., Xiao, Z., Shen, J., Zhao, Y., et al. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.126568 · Cited by 57
Porte, R., Fougeron, D., Muñoz‐Wolf, N., Tabareau, J., Georgel, A., Wallet, F., Paget, C., Trottein, F., Chabalgoity, J. A., Carnoy, C., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01210-15 · Cited by 66
“Remarkably, exogenous stimulation of mucosal TLR signaling following antibiotic therapy restores immune defenses and prevents infections by opportunistic microorganisms (14, 15, 47, 49).”
BackgroundImmune and genetic gardening of the intestinal microbiome
Jacobs, J. P., & Braun, J. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.052 · Cited by 58
“Loss of RegIIIc expression after antibiotic treatment allowed for expansion of an antibiotic-resistant Gram positive pathogen, vancomycin-resistant Enterococcus [62].”
BackgroundLin, X., Yang, M., Li, H., Wang, C., & Peng, X. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2013.12.024 · Cited by 60
“efflux system [1–3].”
BackgroundThe Microbiome, Systemic Immune Function, and Allotransplantation
Nellore, A., & Fishman, J. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00063-15 · Cited by 57
“In addition, antibacterial agents against Gram-positive bacteria have been shown to block local TLR and MyD88 innate immune signaling pathways that are essential for iTreg development (81, 82).”
BackgroundBlyth, G. A. D., Connors, L. T., Fodor, C. C., & Cobo, E. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00965 · Cited by 61
Osteoarthritis Can Also Start in the Gut: The Gut–Joint Axis
Gleason, B., Chisari, E., & Parvizi, J. (2022) · Indian Journal of Orthopaedics · doi:10.1007/s43465-021-00473-8 · Cited by 61
Isaac, S., Flor‐Duro, A., Carruana, G., Puchades‐Carrasco, L., Quirant, A., López‐Nogueroles, M., Pineda‐Lucena, A., Garcia‐Garcerà, M., & Úbeda, C. (2022) · Nature Communications · doi:10.1038/s41467-022-35380-5 · Cited by 58
Inhaled therapeutics for prevention and treatment of pneumonia
Safdar, A., Shelburne, S. A., Evans, S. E., & Dickey, B. F. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903036083 · Cited by 60
“Indeed, the colon of mice is persistently stimulated by the presence of lumenal bacteria, resulting in constitutive activation of StIR that can be revealed as an inducibly reduced capacity for bacterial killing by colonic epithelium after treatment with antibiotics [53], yet the colon does not develop fibrosis.”
BackgroundJung, H.-J., Littmann, E. R., Seok, R., Leiner, I. M., Taur, Y., Peled, J., van den Brink, M., Ling, L., Chen, L., Kreiswirth, B. N., et al. (2019) · mBio · doi:10.1128/mbio.02663-18 · Cited by 45
“Compromised immune defenses in patients undergoing cancer treatment also contribute to dense colonization of the gut by antibiotic-resistant bacteria (10).”
Self-citationJacobson, R. A., Wienholts, K., Williamson, A. J., Gaines, S., Hyoju, S. K., van Goor, H., Zaborin, A., Shogan, B. D., Zaborina, O. Y., & Alverdy, J. C. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00236.2019 · Cited by 52
“faecalis is impaired after gross defaunation of the gut with broad spectrum antibiotics (8, 13).”
BackgroundImpact of the Microbiota on Bacterial Infections during Cancer Treatment
Galloway-Peña, J., Brumlow, C., & Shelburne, S. A. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.06.006 · Cited by 57
Chakraborty, R., Lam, V., Kommineni, S., Stromich, J., Hayward, M., Kristich, C. J., & Salzman, N. H. (2018) · Infection and Immunity · doi:10.1128/iai.00674-18 · Cited by 50
“For example, IgA, which coats intestinal commensals and restricts their mucosal penetration, was shown to be induced in RegIII / mice (47).”
BackgroundInfluentialDevaux, C. A., Million, M., & Raoult, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01642 · Cited by 53
Gorlé, N., Bauwens, E., Haesebrouck, F., Smet, A., & Vandenbroucke, R. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584165 · Cited by 56
Reg3γ: current understanding and future therapeutic opportunities in metabolic disease
Shin, J. H., Bozadjieva-Kramer, N., & Seeley, R. J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01054-5 · Cited by 54
The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution
Reinseth, I. S., Ovchinnikov, K. V., Tønnesen, H. H., Carlsen, H., & Diep, D. B. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09618-6 · Cited by 56
“However, colonization of the gastrointestinal tract is believed to be the first step of infection, and therefore it is of great importance [12, 55, 71, 79, 97, 111].”
BackgroundInfluentialImmunological design of commensal communities to treat intestinal infection and inflammation
Brown, R. L., Larkinson, M. L. Y., & Clarke, T. B. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009191 · Cited by 52
“inflammation, PRR signaling promotes mucosal repair and the restoration of immune homeostasis[11], similarly PRR stimulation can also promote the clearance of pathogens from the intestine[20].”
BackgroundThe Blessings and Curses of Intestinal Inflammation
Winter, S. E., Keestra, A. M., Tsolis, R. M., & Bäumler, A. J. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.003 · Cited by 49
“These antimicrobial mechanisms are likely aimed at clearing lumenal bacteria from the vicinity of the epithelium (Brandl et al., 2007, 2008; Zheng et al., 2008).”
Burrello, C., Garavaglia, F., Cribiù, F. M., Ercoli, G., Bòsari, S., Caprioli, F., & Facciotti, F. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00021 · Cited by 51
“In this context, few recent data indicate that neonatal mice treated with vancomycin or colistin manifest reduced intestinal lymphoid follicles, while broad-spectrum antibiotics administration diminishes antimicrobial peptides production (14).”
BackgroundFeng, J., Wang, L., Xie, Y., Chen, Y., Yi, H., & He, D. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106658 · Cited by 52
Song, B., Li, P., Xu, H., Wang, Z., Yuan, J., Zhang, B., Lv, Z., Song, Z., & Guo, Y. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-022-00788-y · Cited by 50
Khoruts, A., & Weingarden, A. R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.07.016 · Cited by 47
“Treatment of mice with a mix of antibiotics that includes metronidazole and vancomycin, which are routinely used in the care of patients with CDI, results in downregulation of intestinal expression of RegIIIγ, a secreted C-type lectin that kills Gram-positive bacteria [33].”
BackgroundAssociation of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
Chen, Z., Zhang, S., Dong, S., Xu, H., & Zhou, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844401 · Cited by 44
Adaptation of the gut pathobiont Enterococcus faecalis to deoxycholate and taurocholate bile acids
Repoila, F., Wessner, F., Guérin, C., Lacoux, C., Tiwari, S., Jaiswal, A. K., Santana, M. P., Kennedy, S., Quinquis, B., Rainteau, D. P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12552-3 · Cited by 56
Crouzet, L., Rigottier‐Gois, L., & Serror, P. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv012 · Cited by 52
The role of the immune system in regulating the microbiota
Willing, B. P., Gill, N., & Finlay, B. B. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12520 · Cited by 54
Mechanism for maintaining homeostasis in the immune system of the intestine.
Taniguchi, Y., Yoshioka, N., Nakata, K., Nishizawa, T., Inagawa, H., Kohchi, C., & Soma, G. (2009) · PubMed · Cited by 54
Fagan, K. J., Rogers, G. B., Melino, M., Arthur, D. M., Costello, M., Morrison, M., Powell, E. E., & Irvine, K. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120642 · Cited by 45
“of antiobiotic prophylaxis and invasive procedures, highlighting the importance of ensuring appropriate antibiotic use[33] Long term use of broad-spectrum antibiotics may lead to an increase in pathogenic bacteria in the gut and increased antibiotic resistance[33–35].”
BackgroundThe Cell Wall Architecture of Enterococcus Faecium : From Resistance to Pathogenesis
Hendrickx, A. P. A., van Schaik, W., & Willems, R. J. L. (2013) · Future Microbiology · doi:10.2217/fmb.13.66 · Cited by 57
Antibiotic resistant bacteria: A bibliometric review of literature
Sun, G., Zhang, Q., Dong, Z., Dong, D., Fang, H., Wang, C., Dong, Y., Wu, J., Tan, X., Zhu, P., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1002015 · Cited by 52
Metadata
- Authors
- Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California San Diego (US)
- Corresponding author
- Pamer, Eric G.
- Venue
- Nature
- Published
- 2008-08-24
- Volume
- 455
- Issue
- 7214
- Pages
- 804-807
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2663337
- OpenAlex
- W2093972125
- Cited by
- 631
- References
- 28
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 27 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 48 · 2019: 32 · 2018: 56 · 2017: 41 · 2016: 36 · 2015: 39 · 2014: 37 · 2013: 38 · 2012: 39
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Alexander von Humboldt-Stiftung
- National Institutes of Health (4r37ai039031-21)
- National Institute of Allergy and Infectious Diseases (AI42135, R01AI039031, R01AI080619, R37-AI039031, AI 39031, R01AI042135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Keywords
- vancomycin-resistant enterococci, antibiotic resistance, intestinal innate immunity, RegIIIγ, C-type lectin, broad-spectrum antibiotics, TLR4, lipopolysaccharide, mucosal epithelium, commensal bacteria, antibiotic-associated infection, Gram-positive bacteria
- MeSH terms
- Pancreatitis-Associated Proteins, Animals, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Proteins, Vancomycin, Signal Transduction, Down-Regulation, Enterococcus, Vancomycin Resistance, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.